Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Seresis in healthy volunteers
NCT02191787Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 1998
- Primary completion
- May 1998
01
Overview
Phase 1, open-label, single-arm trial of Seresis in Skin aging, sponsored by Boehringer Ingelheim. Primary endpoint: Changes in total antioxidant activity of Seresis® at Day 2. Started Mar 1998; status: completed.
02
Drugs
Seresis
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT02191787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191787.